CD59 and myeloid sarcoma: Others have been implicated in MS pathogenesis, but were never studied in human subjects for their association with disease severity or HPA-axis activity, such as IL7R, tissue transglutaminase (TGM2), MAC-inhibitory protein (CD59), and gap junction alpha-4 (GJA4) [10, 41, 77, 83].